Moximed implants first Misha knee implantable shock absorber
September 6, 2023
Moximed announced today that doctors completed the first commercial cases for its Misha knee system, an implantable shock absorber (ISA).
Moximed announced today that doctors completed the first commercial cases for its Misha knee system, an implantable shock absorber (ISA).
The findings point to faster way to detect bacteria in food, water, and clinical samples.
Mountain View, California-based Levita designed its MARS minimally invasive surgical platform for the high-volume abdominal surgery market. It combines magnets and machines to reduce the number of incisions, enabling complete control during laparoscopic procedures.
How mutation in brain cell leads to ALS and offers path for drugs
The Portrait Mobile device is one of GE HealthCare’s “first major introductions in monitoring in recent years,” according to the company.
MIT engineers developed a new way to create these arrays, by scaffolding quantum rods onto patterned DNA.
In addition to turning on genes involved in cell defense, the STING protein also acts as an ion channel, allowing it to control a wide variety of immune responses.
The new device, which can be incorporated into a bra, could allow more frequent monitoring of patients at high risk for breast cancer.
A tiny robot which can travel deep into the lungs to detect and treat the first signs of cancer has been developed by researchers at the University of Leeds.
Combining two types of heart scan could help doctors to detect a deadly heart condition before symptoms and signs on conventional tests appear, new research co-led by the University of Leeds shows.